H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.53 HKD 4.79% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Hua Medicine?
Write Note

Gross Margin
Hua Medicine

37.7%
Current
27%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.7%
=
Gross Profit
41.1m
/
Revenue
108.9m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CN
Hua Medicine
HKEX:2552
1.5B HKD
38%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
729.3B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
347.8B USD
69%
US
Merck & Co Inc
NYSE:MRK
248.3B USD
77%
CH
Roche Holding AG
SIX:ROG
197.2B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
159B GBP
82%
CH
Novartis AG
SIX:NOVN
169.7B CHF
75%
US
Pfizer Inc
NYSE:PFE
149.4B USD
71%
Country CN
Market Cap 1.5B HKD
Gross Margin
38%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 729.3B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.6T DKK
Gross Margin
85%
Country US
Market Cap 347.8B USD
Gross Margin
69%
Country US
Market Cap 248.3B USD
Gross Margin
77%
Country CH
Market Cap 197.2B CHF
Gross Margin
73%
Country UK
Market Cap 159B GBP
Gross Margin
82%
Country CH
Market Cap 169.7B CHF
Gross Margin
75%
Country US
Market Cap 149.4B USD
Gross Margin
71%
No Stocks Found

Hua Medicine
Glance View

Market Cap
1.5B HKD
Industry
Pharmaceuticals

Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 146 full-time employees. The company went IPO on 2018-09-14. The firm is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The firm mainly operates its business in the domestic and overseas markets.

Intrinsic Value
0.34 HKD
Overvaluation 78%
Intrinsic Value
Price
H

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.7%
=
Gross Profit
41.1m
/
Revenue
108.9m
What is the Gross Margin of Hua Medicine?

Based on Hua Medicine's most recent financial statements, the company has Gross Margin of 37.7%.